<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00715325</url>
  </required_header>
  <id_info>
    <org_study_id>CSP-IL-LIT-0703_S_01</org_study_id>
    <nct_id>NCT00715325</nct_id>
  </id_info>
  <brief_title>ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy</brief_title>
  <official_title>Evaluation of Safety and Efficacy of a New Colonoscope, ProtectiScope CS, to Diagnose Large Bowel Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker GI Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker GI Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the ProtectiScope CS is capable to perform
      diagnostic and therapeutic colonoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ProtectiScope CS is a disposable-based colonoscope incorporating a miniature video
      camera,integral light source along with single-use sleeves and application Channels.

      The ProtectiScope CS is intended to provide visualization and therapeutic access to the Lower
      Gastrointestinal Tract, in adult patient populations.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">January 2009</completion_date>
  <primary_completion_date type="Anticipated">December 2008</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the success rate in reaching within working distance of the Cecum with no complications.</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the ability to perform routine therapeutic interventions such as biopsies, polypectomies, APC etc. as compared to therapeutic interventions with standard colonoscopes found in the literature.</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Protectiscop CS</intervention_name>
    <description>Patients who are indicated for screening colonoscopy will be recruited into the trial. The ProtectiScope CS sleeve is assembled on the colonoscope.standard colonoscopy is performed. Subjects will be followed for 1-month post procedure.</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject between the ages of 18 and 80

          -  Subject is indicated for screening colonoscopy

          -  Subject is willing to sign informed consent form

        Exclusion Criteria:

          -  Subject is suspected, based on radiographic or other clinical grounds, of suffering
             from one or more of the following: full or partial colonic obstruction; acute abdomen;
             gross hematochezia; severely ulcerated colon; diverticulitis; severe diverticulosis;
             toxic megacolon.

          -  Subject has active cardiac problems and history of heart failure, severe pulmonary
             diseases renal failure (creatinine &gt;2) uncontrolled diabetes and any other illness
             judged by investigator to substantiate exclusion.

          -  Subject has a history of significant other diseases.

          -  Subject has a history of psychiatric disorders which would prevent compliance with
             study instructions

          -  For female subjects, suspicion of pregnancy

          -  Subject has received treatment with another investigational drug or device within the
             past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ori Segol, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carmel Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ori Segol, Dr.</last_name>
    <phone>+97248250359</phone>
    <email>Ori_segol@clalit.org.il</email>
  </overall_contact>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2008</study_first_submitted>
  <study_first_submitted_qc>July 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2008</study_first_posted>
  <last_update_submitted>September 17, 2008</last_update_submitted>
  <last_update_submitted_qc>September 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Ori Segol</name_title>
    <organization>Carmel Nedical Center</organization>
  </responsible_party>
  <keyword>colonoscopy</keyword>
  <keyword>disposable</keyword>
  <keyword>single use</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

